CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 1.40 | -0.26 | 1.39 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -143.41 | 57.80 | 71.01 | -2,849.68 |
| Quality | ||||
| ROIC | 0.66% | 1.05% | 0.86% | -0.76% |
| Gross Margin | 54.90% | 57.70% | 57.19% | 54.86% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -6.29% | -7.28% | -5.96% | -3.69% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -143.41 | -27.36 | -34.37 | 951.85 |
| Interest Coverage | 182.15 | 207.58 | 290.26 | -213.63 |
| Efficiency | ||||
| Inventory Turnover | 1.51 | 1.46 | 1.48 | 1.37 |
| Cash Conversion Cycle | 79.15 | 74.00 | 74.77 | 79.19 |